Then, these analyses are expanded to a larger cohort consisting of neuropathologically confirmed control, fAD, sAD, Down syndrome (DS), and frontotemporal lobar degeneration with Tau pathology cases (FTLD-tau). This evidence concerns the gene MAPT and Down syndrome.